Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Outcomes of Second Line Therapy for Light Chain Amyloidosis after Initial Therapy with a Bortezomib Based Regimen

Lipi Chakravorty, Anthea Gibbons, Nirija Anderson, Fiona Kwok, Dariusz Korczyk, Emad Uddin Abro, Stephanie Lam, Simon Gibbs, Peter Mollee, M Hasib Sidiqi

Blood (2023) 142 (Supplement 1): 4781.

https://doi.org/10.1182/blood-2023-186335

Published: 2023

Journal Articles

Cell Free MYC DNA Copy Number Identifies High-Risk Smouldering Myeloma and Newly Diagnosed Multiple Myeloma

Daniel Wong, John Reynold, Cameron Wellard, Nicholas Bingham, Jessie Zhao, Malarmathy Ramachandran, Hang Quach, Simon Gibbs, Tiffany T. Khong, Sridurga Mithraprabhu, Andrew Spencer

Blood (2023) 142 (Supplement 1): 878.

https://doi.org/10.1182/blood-2023-185329

Published: 2023

Journal Articles

Identifying Early Suboptimal Hematological Response in Patients with AL Amyloidosis Treated with Bortezomib-Based Chemotherapy

Anthea Gibbons, Nirija Ranjit Anderson, Lipi Chakravorty, Fiona Kwok, Hasib Sidiqi, Simon Gibbs, Dariusz Korczyk, Emad Uddin Abro, Peter Mollee

Blood (2023) 142 (Supplement 1): 2030.

https://doi.org/10.1182/blood-2023-179219

Published: 2023

Journal Articles

First Report on the Effects of Lisaftoclax (APG-2575) in Combination with Novel Therapeutic Regimens in Patients with Relapsed or Refractory Multiple Myeloma (R/R MM) or Immunoglobulin Light-Chain (Amyloid Light-Chain [AL]) Amyloidosis

Sikander Ailawadhi, Asher A. Chanan-Khan, Costas K. Yannakou, Simon Gibbs, Jack Khouri, Zi Chen, Huanshan Guo, Mingyu Li, Mohammad Ahmad, Cunlin Wang, Dajun Yang, Yifan Zhai

Blood (2023) 142 (Supplement 1): 2016.

https://doi.org/10.1182/blood-2023-188122

Published: 2023

Journal Articles

First Analysis from a Phase 1/2 Study of Venetoclax in Combination with Daratumumab and Dexamethasone, +/- Bortezomib, in Patients with Relapsed/Refractory Multiple Myeloma

Nizar Bahlis, MD, Rachid Baz, MD, Simon Harrison, MBBS, MRCP, FRCPath, FRACP, PhD, Hang Quach, MBBS, FRACP, FRCPA, MD, Shir-Jing Ho, MBBS, FRACP, FRCPA, MClinTrial Res, Annette Juul Vangsted, MD PhD, Philippe Moreau, MD, Simon Gibbs, FRACP, FRCPA, MBBS, Ahmed Hamed Salem, PhD FCP, Jeremy A. Ross, PhD, John Pesko, PhD, Sally Westrup, Jenny Vue, Paulo C. Maciag, MD PhD, Orlando F. Bueno, MD PhD, Jonathan L. Kaufman, MD

Blood (2019) 134 (Supplement_1): 925.

https://doi.org/10.1182/blood-2019-124407

Published: 2019

Journal Articles

Early Serum Free Light Chain (SFLC) Kinetics Is Highly Predictive of Renal Response in Carfilzomib/ Dexamethasone (Cfz/Dex) in Myeloma (MM) Patients with Renal Impairment (RI) — Interim Analysis of the Australian ALLG MM16 Trial

Phoebe Joy Ho, MBBS DPhil FRACP FRCPA, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Peter Mollee, FRACP, FRCPA, MBBS, MMSc, Anoop K Enjeti, MBBS, FRCPA, MD MRCP, Noemi Horvath, MBBS FRACP FRCPA, Christian E Bryant, MBBS, PhD FRACP, FRCPA, Judith Trotman, Simon Gibbs, FRACP, FRCPA, MBBS, Douglas E Joshua, BSc(Hons) MBBS DPhil FRACP FRCPA

Blood (2018) 132 (Supplement 1): 3283.

https://doi.org/10.1182/blood-2018-99-110664

Published: 2018

Journal Articles

ALchemy - A Large Prospective ‘Real World' Study of Chemotherapy in AL Amyloidosis

Thirusha Lane, RN, Lisa Rannigan, RN, Darren Foard, RN, Ashutosh Wechalekar, MD, Simon Gibbs, MD, Jennifer Pinney, MD, Christopher P Venner, MD, Sanjay Banypersad, MD, Helen Lachmann, MD, Philip N Hawkins, MD, Julian D Gillmore, MD

Blood (2011) 118 (21): 992.

https://doi.org/10.1182/blood.V118.21.992.992

Published: 2011

Journal Articles

Chronic Pain Is An Independent Predictor of Lower 6 Minute Walk Distance In Patients with Sickle Cell Disease: Results From Walk-PHaSST Study

Lakshmanan Krishnamurti, MD, Ruchika Goel, Oswaldo Castro, MD, Robyn J. Barst, Erika Berman Rosenzweig, Vandana Sachdev, Roberto F. Machado, Simon Gibbs, Jane A Little, Dean E. Schraufnagel, Reda E. Girgis, Claudia R. Morris, MD, David B. Badesch, Sophie Lanzkron, MD, MHS, Jonathan C. Goldsmith, MD, FACP, Victor R. Gordeuk, MD, Gregory J. Kato, MD, Mark Gladwin, MD, Kathryn Hassell, MD

Blood (2010) 116 (21): 2658.

https://doi.org/10.1182/blood.V116.21.2658.2658

Published: 2010

Journal Articles

Predictors of Six-Minute Walk Distance In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Robyn J. Barst, MD, Gregory J. Kato, MD, Vandana Sachdev, MD, Mehdi Nouraie, MD, Roberto F. Machado, MD, Kathryn Hassell, MD, Simon Gibbs, MD, Jane Little, MD, Dean E. Schraufnagel, MD, Lakshmanan Krishnamurti, MD, Reda E. Girgis, MD, Claudia R. Morris, MD, David B. Badesch, MD, Sophie Lanzkron, MD, MHS, Oswaldo Castro, MD, Erika Berman Rosenzweig, MD, Jonathan C. Goldsmith, MD, FACP, Mark Gladwin, MD, Victor R. Gordeuk, MD

Blood (2010) 116 (21): 947.

https://doi.org/10.1182/blood.V116.21.947.947

Published: 2010

Journal Articles

Cigarette Smoking Is An Independent Predictor of Chronic Pain In Sickle Cell Patients: Results From the Walk-PHaSST Study

Ruchika Goel, MD, MPH, Kathryn Hassell, MD, Oswaldo Castro, MD, Robyn J. Barst, Erika Berman Rosenzweig, Vandana Sachdev, Roberto F. Machado, Simon Gibbs, Jane A Little, Dean E. Schraufnagel, Reda E. Girgis, Claudia R. Morris, MD, David B. Badesch, Sophie Lanzkron, MD, MHS, Jonathan C. Goldsmith, MD, FACP, Victor R. Gordeuk, MD, Gregory J. Kato, MD, Mark Gladwin, MD, Lakshmanan Krishnamurti, MD

Blood (2010) 116 (21): 4804.

https://doi.org/10.1182/blood.V116.21.4804.4804

Published: 2010

Journal Articles

Early Detection of Cardiac Systolic Functional Impairment and Correlation with NT-ProBNP Change in AL Amyloidosis by Cardiac Lateral Wall Tissue Doppler S Wave.

Marna de Cruz, Babita Pawarova, Helen Lachmann, Julian Gillmore, Simon Gibbs, Prayman Sattianayagam, Philip Hawkins, Ashutosh D Wechalekar

Blood (2009) 114 (22): 2814.

https://doi.org/10.1182/blood.V114.22.2814.2814

Published: 2009

Journal Articles

Safety and Efficacy of Sildenafil Therapy for Doppler-Defined Pulmonary Hypertension in Patients with Sickle Cell Disease: Preliminary Results of the Walk-PHaSST Clinical Trial.

Roberto F Machado, MD, Robyn J Barst, MD, Nancy A Yovetich, PhD, Kathryn L Hassell, MD, Jonathan C. Goldsmith, MD, Rob Woolson, MS, JD, Victor R. Gordeuk, MD, Simon Gibbs, MD, Jane A Little, MD, Gregory J Kato, MD, Dean E Schraufnagel, MD, Lakshmanan Krishnamurti, MD, Reda E Girgis, MD, Claudia R. Morris, MD, Erika Berman-Rosenzweig, MD, David B Badesch, MD, Myron A Waclawiw, PhD, Mark Gladwin, MD

Blood (2009) 114 (22): 571.

https://doi.org/10.1182/blood.V114.22.571.571

Published: 2009

Journal Articles

Optimal Timing of Peripheral Blood Stem Cell Mobilisation in Patients with Hematological Malignancies Treated with the Hyper-CVAD Chemotherapy Regimen.

Anthony K. Mills, MBBS, Simon Gibbs, MBBS, Colm Keane, MBBCh BAO, Peter Mollee, MBBS, Karen Grimmett, BApSc, Rosita Van Kuilenburg, Russell Saal, BApSc MMedSci, Devinder Gill, MBChB, H. Miles Prince, MBBS, John F. Seymour, MBBS, Paula Marlton, MBBS

Blood (2004) 104 (11): 5213.

https://doi.org/10.1182/blood.V104.11.5213.5213

Published: 2004

NARROW

Outcomes of Second Line Therapy for Light Chain Amyloidosis after Initial Therapy with a Bortezomib Based Regimen

Cell Free MYC DNA Copy Number Identifies High-Risk Smouldering Myeloma and Newly Diagnosed Multiple Myeloma

Identifying Early Suboptimal Hematological Response in Patients with AL Amyloidosis Treated with Bortezomib-Based Chemotherapy

First Report on the Effects of Lisaftoclax (APG-2575) in Combination with Novel Therapeutic Regimens in Patients with Relapsed or Refractory Multiple Myeloma (R/R MM) or Immunoglobulin Light-Chain (Amyloid Light-Chain [AL]) Amyloidosis

First Analysis from a Phase 1/2 Study of Venetoclax in Combination with Daratumumab and Dexamethasone, +/- Bortezomib, in Patients with Relapsed/Refractory Multiple Myeloma

Early Serum Free Light Chain (SFLC) Kinetics Is Highly Predictive of Renal Response in Carfilzomib/ Dexamethasone (Cfz/Dex) in Myeloma (MM) Patients with Renal Impairment (RI) — Interim Analysis of the Australian ALLG MM16 Trial

ALchemy - A Large Prospective ‘Real World' Study of Chemotherapy in AL Amyloidosis

Chronic Pain Is An Independent Predictor of Lower 6 Minute Walk Distance In Patients with Sickle Cell Disease: Results From Walk-PHaSST Study

Predictors of Six-Minute Walk Distance In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Cigarette Smoking Is An Independent Predictor of Chronic Pain In Sickle Cell Patients: Results From the Walk-PHaSST Study

Early Detection of Cardiac Systolic Functional Impairment and Correlation with NT-ProBNP Change in AL Amyloidosis by Cardiac Lateral Wall Tissue Doppler S Wave.

Safety and Efficacy of Sildenafil Therapy for Doppler-Defined Pulmonary Hypertension in Patients with Sickle Cell Disease: Preliminary Results of the Walk-PHaSST Clinical Trial.

Optimal Timing of Peripheral Blood Stem Cell Mobilisation in Patients with Hematological Malignancies Treated with the Hyper-CVAD Chemotherapy Regimen.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only